InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| TLR4-based adjuvant - MPLA-SM VacciGrade™ | Enhanced Immunogenicity of an Influenza Ectodomain Matrix-2 Protein Virus-lik... | 2022 | Viruses | Gomes K.B. et al. | DOI: 10.3390/v14091920 |
| Alhydrogel® adjuvant 2% | Enhanced Immunogenicity of an Influenza Ectodomain Matrix-2 Protein Virus-lik... | 2022 | Viruses | Gomes K.B. et al. | DOI: 10.3390/v14091920 |
| THP1-Blue™ NF-κB Cells | Neuroprotective Effects of the Lithium Salt of a Novel JNK Inhibitor in an An... | 2022 | Biomedicines | Schepetkin I.A. et al. | DOI: 10.3390/biomedicines10092119 |
| QUANTI-Blue™ | Neuroprotective Effects of the Lithium Salt of a Novel JNK Inhibitor in an An... | 2022 | Biomedicines | Schepetkin I.A. et al. | DOI: 10.3390/biomedicines10092119 |
| LumiKine™ Xpress mIFN-β 2.0 | Immune checkpoint inhibition improves antimyeloma activity of bortezomib and ... | 2022 | Clin Exp Med. | Sokolowska O. et al. | DOI: 10.1007/s10238-022-00878-1 |
| 2’3’-cGAM(PS)2 (Rp/Sp) | Immune checkpoint inhibition improves antimyeloma activity of bortezomib and ... | 2022 | Clin Exp Med. | Sokolowska O. et al. | DOI: 10.1007/s10238-022-00878-1 |
| Alhydrogel® adjuvant 2% | Alum-anchored intratumoral retention improves the tolerability and antitumor ... | 2022 | PNAS | Lutz E.A. et al. | DOI: 10.1073/pnas.2205983119 |
| HKEB | Carbon-Based Nanomaterials Increase Reactivity of Primary Monocytes towards V... | 2021 | Nanomaterials (Basel) | Svadlakova T. et al. | DOI: 10.3390/nano11102510 |
| Human TLR2 Reporter HEK293 Cells (NF-κB) | Carbon-Based Nanomaterials Increase Reactivity of Primary Monocytes towards V... | 2021 | Nanomaterials (Basel) | Svadlakova T. et al. | DOI: 10.3390/nano11102510 |
| Human TLR4 Reporter HEK293 Cells (NF-κB) | Carbon-Based Nanomaterials Increase Reactivity of Primary Monocytes towards V... | 2021 | Nanomaterials (Basel) | Svadlakova T. et al. | DOI: 10.3390/nano11102510 |
| IL-6 Reporter HEK 293 Cells | Carbon-Based Nanomaterials Increase Reactivity of Primary Monocytes towards V... | 2021 | Nanomaterials (Basel) | Svadlakova T. et al. | DOI: 10.3390/nano11102510 |
| HKSA | Carbon-Based Nanomaterials Increase Reactivity of Primary Monocytes towards V... | 2021 | Nanomaterials (Basel) | Svadlakova T. et al. | DOI: 10.3390/nano11102510 |
| Normocin™ - Antimicrobial Reagent | Carbon-Based Nanomaterials Increase Reactivity of Primary Monocytes towards V... | 2021 | Nanomaterials (Basel) | Svadlakova T. et al. | DOI: 10.3390/nano11102510 |
| QUANTI-Blue™ | Carbon-Based Nanomaterials Increase Reactivity of Primary Monocytes towards V... | 2021 | Nanomaterials (Basel) | Svadlakova T. et al. | DOI: 10.3390/nano11102510 |
| HEK-Blue™ Selection | Carbon-Based Nanomaterials Increase Reactivity of Primary Monocytes towards V... | 2021 | Nanomaterials (Basel) | Svadlakova T. et al. | DOI: 10.3390/nano11102510 |
| IL-10 Reporter HEK 293 Cells | Carbon-Based Nanomaterials Increase Reactivity of Primary Monocytes towards V... | 2021 | Nanomaterials (Basel) | Svadlakova T. et al. | DOI: 10.3390/nano11102510 |
| Primocin® | Carbon-Based Nanomaterials Increase Reactivity of Primary Monocytes towards V... | 2021 | Nanomaterials (Basel) | Svadlakova T. et al. | DOI: 10.3390/nano11102510 |
| HKMT | Single-cell RNA-sequencing of peripheral blood mononuclear cells reveals wide... | 2022 | Nat Commun. | Oelen R. et al. | DOI: 10.1038/s41467-022-30893-5 |
| PMA - Phorbol myristate acetate | Immunogenicity and protectivity of intranasally delivered vector-based hetero... | 2022 | Emerg Microbes Infect. | Tukhvatulin A.I. et al. | DOI: 10.1080/22221751.2022.2119169 |
| PlasmoTest™ - Mycoplasma Detection Kit | A novel serum extracellular vesicle protein signature to monitor glioblastoma... | 2022 | Int J Cancer | Tzaridis T. et al. | DOI: 10.1002/ijc.34261 |